Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CALM1 | P0DP23 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | TSHR | P16473 | 2/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10102406 | 0.95 | SLC2A1 (0.36) | CALM1ALDH1A1TSHRKDM4EMEN1 | |
| SCHEMBL10102268 | 0.88 | SLC2A1 (0.36) | ALDH1A1TSHRKDM4EMEN1LMNA | |
| SCHEMBL7528138 | 0.88 | MEN1 (0.33) | CALM1ALDH1A1TSHRKDM4EMEN1 | |
| SCHEMBL6131956 | 0.87 | SLC2A1 (0.35) | CALM1ALDH1A1TSHRKDM4EMEN1 | |
| SCHEMBL7525851 | 0.85 | TDP1 (0.32) | CALM1ALDH1A1TSHRKDM4EMEN1 | |
| SCHEMBL10106936 | 0.83 | SLC2A1 (0.36) | ALDH1A1TSHRKDM4EMEN1LMNA | |
| SCHEMBL7534540 | 0.81 | CNR1 (0.32) | ALDH1A1KDM4ELMNAHTT | |
| SCHEMBL10102271 | 0.78 | MEN1 (0.34) | ALDH1A1TSHRKDM4EMEN1HPGD | |
| SCHEMBL7528995 | 0.78 | ALDH1A1 (0.37) | ALDH1A1TSHRKDM4EMEN1LMNA | |
| SCHEMBL7528300 | 0.74 | PKM (0.37) | ALDH1A1TSHRKDM4EMEN1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8147726-B2 | Chromene compound | TOKUYAMA CORPORATION (JP) | 2012-04-03 | — | — | US | disclosed |
| US-20110062396-A1 | CHROMENE COMPOUND | TOKUYAMA CORPORATION (JP) | 2011-03-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110062396-A1 | CHROMENE COMPOUND | CDYL, NR0B1, NR1H2 | CALM1 3337/4885ALDH1A1 1987/4885TSHR 330/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.